Figure 5From: Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancerCorrelation between OS and ISR. The local immune reactions at the site of injection were observed in 23 patients. MST of the patients who had injection site reaction was 182 days, while MST of the patients without such reaction (n = 6) was 42 days (p < 0.0001).Back to article page